DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years

Châtillon, France, September 29, 2026DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 YearsDBV Technologies (Euronext: DBV — ISIN: FR0010417345 — Nasdaq Stock Market: DBVT), a late-stage biopharmaceutical company…